Date | Time | Source | Headline | Symbol | Company |
11/20/2007 | 2:39PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/19/2007 | 11:12AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/15/2007 | 5:12PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/15/2007 | 4:06PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/15/2007 | 7:00AM | PR Newswire (US) | Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/13/2007 | 3:10PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) (424B3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/13/2007 | 1:51PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/06/2007 | 4:07PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
11/06/2007 | 1:08PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/31/2007 | 5:29PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/31/2007 | 4:00PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/31/2007 | 1:46PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/31/2007 | 12:18PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/31/2007 | 6:00AM | PR Newswire (US) | Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/31/2007 | 6:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Conference Call | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/30/2007 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/29/2007 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at BIOCOM Investor Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/19/2007 | 11:34AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/19/2007 | 11:30AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/17/2007 | 4:20PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/17/2007 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/17/2007 | 12:14PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/17/2007 | 12:14PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/17/2007 | 10:53AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/17/2007 | 10:53AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/17/2007 | 10:53AM | PR Newswire (US) | Seven Summits Research Releases Comments on EBAY, JPM, LUV, AMLN, and GCI | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/11/2007 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/09/2007 | 11:56AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/09/2007 | 11:53AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
10/09/2007 | 11:51AM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |